Cadrenal Therapeutics, Inc. Debt Instrument, Redemption Price, Percentage
Cadrenal Therapeutics, Inc. (CVKD) reported Debt Instrument, Redemption Price, Percentage of 20.00% for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-10.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentRedemptionPricePercentage · last filed 2023-11-09
- Cadrenal Therapeutics, Inc. debt instrument, redemption price, percentage for the quarter ending 2023-03-31 was 20.00%.
| Period end | Debt Instrument, Redemption Price, Percentage 1 month | Debt Instrument, Redemption Price, Percentage 3 month | Debt Instrument, Redemption Price, Percentage 6 month | Debt Instrument, Redemption Price, Percentage 11 month |
|---|---|---|---|---|
| 2023-06-30 | 20.00% 10-Q · filed 2023-08-10 | |||
| 2023-03-31 | 20.00% 10-Q · filed 2023-05-10 | |||
| 2022-12-31 | 20.00% 10-K · filed 2023-03-30 | |||
| 2022-06-30 | 60.00% 10-Q · filed 2023-11-09 | |||
| 2022-03-31 | 80.00% 10-Q · filed 2023-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B |